Arteris, Inc. (NASDAQ:AIP) Short Interest Update

Arteris, Inc. (NASDAQ:AIPGet Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 15th, there was short interest totaling 1,860,000 shares, anincreaseof70.6% from the July 31st total of 1,090,000 shares. Currently,6.6% of the shares of the stock are sold short. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is presently 1.8 days. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is presently 1.8 days. Currently,6.6% of the shares of the stock are sold short.

Analyst Ratings Changes

A number of research analysts recently issued reports on AIP shares. Rosenblatt Securities reaffirmed a “buy” rating and set a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st. Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a report on Saturday, August 30th. Finally, TD Cowen lifted their target price on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, Arteris currently has an average rating of “Buy” and an average price target of $15.00.

Check Out Our Latest Stock Report on Arteris

Insider Transactions at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 50,000 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total transaction of $656,000.00. Following the transaction, the insider directly owned 9,839,071 shares of the company’s stock, valued at $129,088,611.52. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO K Charles Janac sold 94,245 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.49, for a total value of $1,271,365.05. Following the transaction, the chief executive officer directly owned 189,785 shares in the company, valued at approximately $2,560,199.65. The trade was a 33.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 492,989 shares of company stock valued at $5,823,031 in the last three months. 29.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Arteris

A number of institutional investors have recently bought and sold shares of AIP. Raymond James Financial Inc. acquired a new stake in Arteris during the 2nd quarter worth about $32,000. CWM LLC boosted its position in Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock worth $71,000 after acquiring an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. acquired a new stake in Arteris during the 1st quarter worth about $95,000. Savant Capital LLC acquired a new stake in Arteris during the 2nd quarter worth about $97,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in Arteris during the 2nd quarter worth about $104,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Trading Up 0.2%

Shares of AIP opened at $8.86 on Friday. The business’s 50-day moving average price is $9.52 and its 200 day moving average price is $8.24. The stock has a market capitalization of $377.88 million, a P/E ratio of -10.80 and a beta of 1.44. Arteris has a 1-year low of $5.46 and a 1-year high of $14.29.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million for the quarter, compared to analysts’ expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts predict that Arteris will post -0.73 earnings per share for the current year.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.